精神分裂症妊娠应获全球卫生议程更高优先级:43,611例分娩与40,948,272例对照的大规模荟萃分析
该研究系统检索并荟萃分析了1999至2021年间11个高收入国家26项基于人群的研究,比较精神分裂症产妇(N=43,611)与对照(N=40,948,272)的妊娠、分娩、新生儿及婴儿结局。结果显示精神分裂症与妊娠期糖尿病、子痫前期/子痫、早产、极早产、死产及婴儿死亡等多种不良结局风险升高相关。作者指出中低收入国家尚无基于人群的研究,需更多研究以优化照护和定义最佳实践。
要点
- 精神分裂症产妇极早产(OR 2.31)、死产(OR 2.06)和婴儿死亡(OR 2.33)风险显著升高。
- 精神分裂症产妇妊娠期糖尿病风险升高(OR 2.35),提示代谢风险增加。
- 新生儿期死亡(OR 1.41)、新生儿后期死亡(OR 2.87)风险均升高。
核心结论
- 这项大规模荟萃分析证实精神分裂症与极早产、死产和婴儿死亡风险显著增加以及母亲代谢风险相关。
- 中低收入国家尚无基于人群的研究,而当地精神分裂症女性的健康问题可能更为突出。
- 需要更多研究以更好理解精神分裂症女性及其新生儿的复杂需求、确定如何优化照护提供并定义最佳实践。
研究设计与样本
- 系统综述与荟萃分析,采用随机效应模型,纳入1999至2021年间11个高收入国家的26项基于人群的研究。
- 比较精神分裂症产妇及其新生儿(N=43,611)与对照(N=40,948,272)的妊娠、分娩、新生儿并发症及婴儿死亡结局。
- 研究注册号:PROSPERO CRD42020197446。
主要发现
- 精神分裂症产妇妊娠期糖尿病OR 2.35(95% CI: 1.57-3.52),妊娠期高血压OR 1.55(95% CI: 1.02-2.36),子痫前期/子痫OR 1.85(95% CI: 1.52-2.25)。
- 产前出血OR 2.28(95% CI: 1.58-3.29),产后出血OR 1.14(95% CI: 1.04-1.24),胎盘早剥OR 2.20(95% CI: 2.02-2.39),先兆早产OR 2.91(95% CI: 1.57-5.40),胎膜早破OR 1.29(95% CI: 1.06-1.58)。
- 剖宫产OR 1.33(95% CI: 1.22-1.45),胎儿窘迫OR 1.80(95% CI: 1.43-2.26),早产OR 1.79(95% CI: 1.62-1.98),极早产OR 2.31(95% CI: 1.78-2.98)。
- 小于胎龄儿OR 1.63(95% CI: 1.48-1.80),低出生体重OR 1.75(95% CI: 1.46-2.11),先天畸形OR 1.86(95% CI: 1.71-2.03),死产OR 2.06(95% CI: 1.83-2.31)。
- 新生儿死亡OR 1.41(95% CI: 1.03-1.94),新生儿后期死亡OR 2.87(95% CI: 2.11-3.89),婴儿死亡OR 2.33(95% CI: 1.81-3.01)。
关键数值与推荐
- 妊娠期糖尿病OR 2.35(95% CI: 1.57-3.52),妊娠期高血压OR 1.55(95% CI: 1.02-2.36),子痫前期/子痫OR 1.85(95% CI: 1.52-2.25)。
- 产前出血OR 2.28(95% CI: 1.58-3.29),产后出血OR 1.14(95% CI: 1.04-1.24),胎盘早剥OR 2.20(95% CI: 2.02-2.39),先兆早产OR 2.91(95% CI: 1.57-5.40),胎膜早破OR 1.29(95% CI: 1.06-1.58)。
- 剖宫产OR 1.33(95% CI: 1.22-1.45),胎儿窘迫OR 1.80(95% CI: 1.43-2.26),早产OR 1.79(95% CI: 1.62-1.98),极早产OR 2.31(95% CI: 1.78-2.98)。
- 小于胎龄儿OR 1.63(95% CI: 1.48-1.80),低出生体重OR 1.75(95% CI: 1.46-2.11),先天畸形OR 1.86(95% CI: 1.71-2.03),死产OR 2.06(95% CI: 1.83-2.31)。
- 新生儿死亡OR 1.41(95% CI: 1.03-1.94),新生儿后期死亡OR 2.87(95% CI: 2.11-3.89),婴儿死亡OR 2.33(95% CI: 1.81-3.01)。
临床怎么用
- 该荟萃分析结果可为卫生政策制定者优先安排和組織围产期服务提供依据。
- 研究强调需更多研究以理解精神分裂症女性及其新生儿的复杂需求、优化照护提供并定义最佳实践。
局限性
- 中低收入国家尚无基于人群的研究,而当地精神分裂症女性的健康问题可能更为突出。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Women with schizophrenia and their newborns are at risk of adverse pregnancy, delivery, neonatal and child outcomes. However, robust and informative epidemiological estimates are lacking to guide health policies to prioritise and organise perinatal services. For the first time, we carried out a systematic review and meta-analysis to synthesise the accumulating evidence on pregnancy, delivery, neonatal complications, and infant mortality among women with schizophrenia and their newborns (N = 43,611) vs. controls (N = 40,948,272) between 1999 and 2021 (26 population-based studies from 11 high-income countries) using random effects. Women with schizophrenia had higher odds (OR) of gestational diabetes (2.35, 95% CI: [1.57-3.52]), gestational hypertension, pre-eclampsia/eclampsia (OR 1.55, 95% CI: [1.02-2.36]; 1.85, 95% CI: [1.52-2.25]), antepartum and postpartum haemorrhage (OR 2.28, 95% CI: [1.58-3.29]; 1.14, 95% CI: [1.04-1.24]), placenta abruption, threatened preterm labour, and premature rupture of membrane (OR 2.20, 95% CI: [2.02-2.39]; 2.91, 95% CI: [1.57-5.40]; 1.29, 95% CI: [1.06-1.58]), c-section (OR 1.33, 95% CI: [1.22-1.45]), foetal distress (OR 1.80, 95% CI: [1.43-2.26]), preterm and very preterm delivery (OR 1.79, 95% CI: [1.62-1.98]; 2.31, 95% CI: [1.78-2.98]), small for gestational age and low birth weight (OR 1.63, 95% CI: [1.48-1.80]; 1.75, 95% CI: [1.46-2.11]), congenital malformations (OR 1.86, 95% CI: [1.71-2.03]), and stillbirths (OR 2.06, 95% CI: [1.83-2.31]). Their newborns had higher odds of neonatal death (OR 1.41, 95% CI: [1.03-1.94]), post-neonatal death (OR 2.87, 95% CI: [2.11-3.89]) and infant mortality (OR 2.33, 95% CI: [1.81-3.01]). This large-scale meta-analysis confirms that schizophrenia is associated with a substantially increased risk of very preterm delivery, stillbirth, and infant mortality, and metabolic risk in mothers. No population-based study has been carried out in low- and middle-income countries in which health problems of women with schizophrenia are probably more pronounced. More research is needed to better understand the complex needs of women with schizophrenia and their newborns, determine how care delivery could be optimised, and define best practices. Study registration: PROSPERO CRD42020197446.
引用
- Etchecopar-Etchart D, Mignon R, Boyer L, et al. Schizophrenia pregnancies should be given greater health priority in the global health agenda: results from a large-scale meta-analysis of 43,611 deliveries of women with schizophrenia and 40,948,272 controls. Mol Psychiatry. 2022. PMID: 35804094. doi:10.1038/s41380-022-01593-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。